Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true and openWorldHint=true, so the safety profile is covered. The description adds that the evidence is "public" and from "live-simulation" (i.e., simulated rather than realized performance), which is genuinely useful context, but says nothing about freshness, volume of results, or what a caller receives.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

Two short sentences with the scope statement front-loaded, so it is efficiently sized. However, the trailing caveat about "non-selected market packages" is cryptic and consumes space without adding usable information.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

The tool is simple (no params, read-only) but has no output schema, so the description is the only source for what "evidence" and "rate" actually contain — and it leaves that undefined. Adequate to know it is a safe read, insufficient to know what comes back.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The tool takes zero parameters, so the baseline is 4; there is nothing for the description to disambiguate. No parameter-related omissions exist.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

It has a clear verb ("Read") and names the source ("evidence ... selected by Trading Zones Selector"), but the key noun "evidence" and its "rate" are never defined, so the agent cannot tell concretely what is returned. It does not differentiate itself from the sibling prepare_*/discover_* tools, which makes the purpose only marginally distinguishable.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

There is no statement of when to call this versus the purchase-preparation or discovery siblings. The second sentence ("The rate does not describe every non-selected market package") reads as a disclaimer about interpreting results, not as guidance on invocation.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.